Abiopharma

🔍 Hagen Thomas B (Director)

Company: ERIE INDEMNITY CO (ERIE)

Report Date: 2026-04-20

Detailed Transactions and Holdings:

• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-20 | Code: H | shares_owned_after: 5,100.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-20 | Code: H | nature_of_ownership: Susan H. Hagen Non-Exempt Marital Irrev Trust | shares_owned_after: 6,658,800.00 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-20 | Code: H | nature_of_ownership: Family L.P. | shares_owned_after: 10,086,059.00 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-20 | Code: H | nature_of_ownership: Estate of Susan H. Hagen | shares_owned_after: 12,230.00 | Footnotes: F1
• Acquired 39 shares of Directors' Deferred Compensation Share Credits (Derivative)
  Date: 2026-04-20 | Code: J | equity_swap_involved: 0 | shares_owned_after: 14,378.26 | transaction_form_type: 4 | Footnotes: F3, F4, F5, F5
• Holds 28,800 shares of Class B Common Stock (Derivative)
  Date: 2026-04-20 | Code: H | shares_owned_after: 12.00 | Footnotes: F6, F6, F6, F1
• Holds 9,600 shares of Class B Common Stock (Derivative)
  Date: 2026-04-20 | Code: H | shares_owned_after: 4.00 | Footnotes: F6, F6, F6
• Holds 415,200 shares of Class B Common Stock (Derivative)
  Date: 2026-04-20 | Code: H | shares_owned_after: 173.00 | Footnotes: F6, F6, F6, F2

Footnotes:

• F1: These shares were owned by Erie Indemnity Company director and reporting person, Susan Hirt Hagen who died 6/15/15. By operation of law, her 6,658,800 Class A shares and 12 Class B shares held in a revocable trust passed to an irrevocable trust of which this reporting person became co-trustee, sharing voting and investment powers. The 12,230 Class A shares from Mrs. Hagen's Directors' Deferred Compensation Plan account were subsequently transferred by the Company to her estate for which this reporting person is co-executor, sharing voting and investment powers. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
• F2: These shares are held by the Hagen FLP of which the reporting person is a Limited Partner and the General Partner with the sole powers of investment and voting. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
• F3: Conversion price is not applicable to shares granted under the Outside Directors' Deferred Compensation Plan.
• F4: Acquired under Directors' Deferred Compensation Plan.
• F5: The shares subject to this reporting are Share Credits which are periodically credited to the accounts of certain Directors of Erie Indemnity Company pursuant to its Outside Directors' Stock Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual's service as a Director of the Company ends. There are no exercisable or expiration dates for these securities.
• F6: Pursuant to the Articles of Incorporation of the Company, as amended, shares of Class B Common Stock (voting) of Erie Indemnity Company are convertible at any time to shares of Class A Common Stock (non-voting) at a conversion rate of 2,400 shares of Class A Stock for each share of Class B Stock. There are no exercise or expiration dates associated with this conversion feature and no specific exercise price when a Class B share is converted into Class A shares.